• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

快速检索引用检索图表检索高级检索

• 投稿 • 上一篇    下一篇

动态监测脑脊液ADA变化对评估结核性脑膜炎疾病转归的意义

王永峰,陈庆,侯永华,查月芳,高金昙   

  1. (河北省胸科医院普内科,石家庄 050041)
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2016-08-25

Dynamic Monitoring of Cerebrospinal Fluid Adenosine Deaminase(ADA) Prognosis of Tuberculous Meningitis Changes to Assess the Significance of Disease

Wang Yong-feng,Chen Qing,Hou Yong-hua,et al.   

  1. (Department of Internal Medicine,Hebei Provincial Chest Hospital,Shijiazhuang 050041, China)
  • Received:1900-01-01 Revised:1900-01-01 Online:2016-08-25

摘要: 【摘要】目的:探究动态监测脑脊液腺苷脱氨酶(ADA)变化对评估结核性脑膜炎疾病转归的意义。方法:选择57例结核性脑膜炎患者为研究对象,采用酶显色剂检测患者的ADA水平,对比是否合并败血症患者、预后良好和不良、不同治疗时期的ADA水平。结果:合并重症败血症组患者的ADA水平显著高于其它未合并组和轻度败血症组,差异有统计学意义(P<0.05)。入院时ADA水平显著高于治疗第3、6、9周水平,差异有统计学意义(P<0.05);治疗时间越长,ADA水平越低。 预后良好组患者的ADA水平显著低于预后不良组,两组患者的ADA水平差异有统计学意义(P<0.05)。初次治疗后半年回访显示,复发18例,未复发39例。复发患者的ADA水平显著高于未复发组,且与初次治疗前水平差异不显著。二次治疗后复发组的ADA水平显著降低,并恢复正常。但因初次治疗不彻底或者耐药,预后仍然很差。结论:ADA水平可作为评价患者预后质量的重要指标,初次治疗时ADA水平越低,患者的病情越轻,预后质量越好;复发后的患者,即使经过治疗,ADA下降至正常范围,一般预后仍然很差。治疗时应注重初治疗效,预防耐药性,降低复发率。

Abstract: 【ABSTRACT】Objective: To explore the significance of the changes in the dynamic monitoring of cerebrospinal fluid adenosine deaminase(ADA)to assess TB meningitis disease outcomes.Methods:57 cases of patients with tuberculous meningitis were selected as the study subjects.The levels of ADA were detected by enzyme reagent,and the levels of ADA in patients with sepsis,good prognosis,poor prognosis and different treatment stages were compared.Results:ADA levels in complicated with severe sepsis patients were significantly higher than those in other unconsolidated and mild sepsis group and control group,the difference is statistically significant(P<0.05).Admission always adenosine deaminase level was significantly higher than that of the 3,6,9 weeks the level of treatment,the difference is statistically significant(P<0.05); the longer treatment time,the lower the levels of adenosine deaminase.Good prognosis group of adenosine deaminase level was significantly lower than that of the poor prognosis group,the patients in the two groups of adenosine deaminase level differences have statistical significance(P<0.05).For the first time after six months showed a return visit recurrence occurred in 18 cases,39 cases without recurrence,recurrence of adenosine deamination The level of enzyme was significantly higher than that of the non relapse group,and the difference was not significant.The level of ADA was significantly decreased after the two treatment,and the recovery was normal,but the prognosis is still poor due to the initial treatment is not completely or drug resistant.Conclusion:Levels of cerebrospinal fluid adenosine deaminase(ADA)can be used as an important index to evaluate prognosis and quality of life of patients,the initial treatment is the lower the level of ADA in patients with disease of the light,the prognosis,the better the quality; recurrence patients,even after treatment of ADA decreased to normal range,generally the prognosis is still poor.Treatment should pay attention to the initial treatment effect,prevention of resistance,reduce the recurrence rate.